Proteome Sciences plc (LON:PRM – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 1.56 and traded as high as GBX 1.85. Proteome Sciences shares last traded at GBX 1.85, with a volume of 132,097 shares changing hands.
Proteome Sciences Stock Performance
The stock has a market cap of £5.44 million, a price-to-earnings ratio of -1.49 and a beta of 0.22. The firm’s 50 day moving average is GBX 1.56 and its two-hundred day moving average is GBX 1.93. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46.
Proteome Sciences (LON:PRM – Get Free Report) last released its quarterly earnings data on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.The business had revenue of GBX 376 million for the quarter.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
